Nav: Home

Forgotten immune cells protective in mouse model of multiple sclerosis

August 07, 2019

Forgotten immune cells protective in mouse model of multiple sclerosis, Stanford study finds

A seldom-studied class of immune cells may reduce the friendly fire that drives autoimmune disease, according to a new study by researchers at the Stanford University School of Medicine. Stimulating these protective cells could lead to new therapies for diseases in which the immune system attacks the body's own tissues, such as multiple sclerosis and celiac disease.

In the study, to be published Aug. 7 in Nature, researchers tracked immune cells in the blood of mice with a disease akin to multiple sclerosis. They discovered a rise in CD8 T cells, typically known for killing infected or cancerous cells. To their surprise, injecting mice with peptides recognized by these CD8 T cells reduced disease severity and killed disease-causing immune cells.

While the bulk of the study was done in mice, the researchers also showed that one of their central findings -- an increase in CD8 T cells derived from single cells -- held true in cells from people with multiple sclerosis.

The findings suggest that inflammatory and suppressive immune cells balance each other like children on a seesaw. Selectively activating suppressive CD8 T cells during autoimmune disease may help restore that balance, said Mark Davis, PhD, professor of microbiology and immunology and the study's senior author.

"We absolutely think that something like this is happening in human autoimmune diseases. It represents a mechanism that nobody's really appreciated. There's this whole subset of CD8 T cells that has a suppressive function," said Davis, who holds the Burt and Marion Avery Family Professorship and is also a Howard Hughes Medical Institute investigator. "If we could mobilize those cells to function more effectively in patients with autoimmunity, then we'd have a novel treatment for diseases like multiple sclerosis."

Attack of the T cell clones

In most cases, researchers don't know what molecules trigger autoimmune diseases, which affect 23.5 million Americans, according to the National Institutes of Health.

Multiple sclerosis is no exception. But scientists can trigger a similar disease in mice by injecting them with a small chunk, or peptide, of a protein called myelin oligodendrocyte glycoprotein, or MOG. Mice with the disease, known as experimental autoimmune encephalomyelitis, develop paralysis just like patients with multiple sclerosis.

The researchers used this mouse model of the disease to investigate what different immune cells were doing during autoimmunity. They tracked the abundance of various classes of immune cells in mice injected with MOG.

They found that the number of T cells, which act like generals in directing the overall scale and strategy behind an immune response, rose and fell like waves. DNA sequencing showed that those waves were each made of groups of identical cells -- an important clue.

"When T cells encounter a pathogen, or antigen, single cells that recognize some part of the pathogen divide and produce many copies of themselves," said research associate Naresha Saligrama, PhD, the study's lead author. "This suggested that a specific population of cells were responding."

But what were these T cells responding to? Saligrama first tested the most obvious suspect: MOG. He exposed the cells to 350 peptides derived from MOG. But while MOG caused some T cells to proliferate, there was a group of CD8 T cells that didn't respond to any of the peptides.

So instead, the researchers cast a much wider net: They tested roughly 5 billion peptides. They used a molecular technique known as yeast display to generate an array of peptides attached to individual yeast cells.

"We are crowdsourcing the T cells. We're asking the T cells, as the disease is progressing, what they are interested in," Davis said. "We're not trying to guess or hypothesize what they are recognizing."

Resurrecting the Titanic

The researchers found two peptides recognized by CD8 T cells involved in the disease. To understand the role of these peptides, they injected them into mice before, after or alongside MOG. Since CD8 T cells are mainly known for killing cancerous and infected cells, the scientists expected that activating these cells would worsen disease.

They were wrong. Activating the CD8 T cells by administering the two peptides consistently reduced or prevented disease in the mice. It was the exact opposite of what they'd expected.

The startling finding forced the researchers to unearth an idea first proposed in the 1970s: that some CD8 T cells are immunosuppressive. After a flurry of initial interest and promising papers, faith in suppressor CD8 T cells sunk once speculation outpaced the actual data.

"Suppressor CD8 T cells did for immunology what the Titanic did for the cruise industry," Davis said.

Davis and his colleagues found that these peptide-activated CD8 T cells killed disease-causing T cells by punching holes in their cell membrane when grown together in a dish. The CD8 T cells were also coated with surface proteins associated with immunosuppression -- yet another clue that these cells were in fact suppressor CD8 T cells.

To determine whether their mouse observations held up in humans, the researchers isolated CD8 T cells from the blood of people with multiple sclerosis and healthy donors. They found that people with the disease tended to have large populations of identical CD8 T cells -- just like in mice with the analogous disease. It's a sign that CD8 T cells in multiple sclerosis are homing in on something, and Davis' team is now working to determine what these cells are recognizing and if some of them are suppressive.

The researchers also plan to test if suppressor CD8 T cells are involved in other autoimmune diseases. Previous findings from the Davis lab suggest that a similar mechanism may be at work in celiac disease. These efforts have the potential to shed new light on how autoimmune diseases work and to uncover new therapeutic targets.

"Crowdsourcing T cells is a fundamentally different way to look at disease," Davis said. "This project shows not only the power of this approach but the power to discover new mechanisms."
Davis is the director of the Stanford Institute for Immunity, Transplantation and Infection. He is also a member of Stanford Bio-X, the Stanford Cancer Institute, the Stanford Cardiovascular Institute, the Stanford Maternal & Child Health Research Institute and the Wu Tsai Neurosciences Institute at Stanford.

Other Stanford co-authors of the study are postdoctoral scholars Fan Zhao, PhD, and Ricardo Fernandes, PhD; graduate student Michael Sikora; research assistants William Serratelli and Winnie Yao; bioinformatics analyst David Louis; research associate Xuhuai Ji, MD, PhD; Juliana Idoyaga, PhD, assistant professor of microbiology and immunology; Vinit Mahajan, MD, PhD, associate professor of ophthalmology; Lars Steinmetz, PhD, professor of genetics; Yueh-Hsiu Chien, PhD, professor of microbiology and immunology; and Christopher Garcia, PhD, professor of molecular and cellular physiology and of structural biology.

Researchers from the University of California-San Francisco also contributed to the study.

This research was supported by the Howard Hughes Medical Institute, the National Institute of Allergy and Infectious Diseases (U19AI057229), the National Multiple Sclerosis Society and the Simons Foundation.

Stanford's Department of Microbiology and Immunology also supported the work.

The Stanford University School of Medicine consistently ranks among the nation's top medical schools, integrating research, medical education, patient care and community service. For more news about the school, please visit The medical school is part of Stanford Medicine, which includes Stanford Health Care and Stanford Children's Health. For information about all three, please visit

Print media contact: Bruce Goldman at (650) 725-2106 (

Broadcast media contact: Becky Bach at (530) 415-0507 (

Stanford Medicine

Related Science Articles:

75 science societies urge the education department to base Title IX sexual harassment regulations on evidence and science
The American Educational Research Association (AERA) and the American Association for the Advancement of Science (AAAS) today led 75 scientific societies in submitting comments on the US Department of Education's proposed changes to Title IX regulations.
Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers
The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.
Science in the palm of your hand: How citizen science transforms passive learners
Citizen science projects can engage even children who previously were not interested in science.
Applied science may yield more translational research publications than basic science
While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May 9, 2018 in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.
Prominent academics, including Salk's Thomas Albright, call for more science in forensic science
Six scientists who recently served on the National Commission on Forensic Science are calling on the scientific community at large to advocate for increased research and financial support of forensic science as well as the introduction of empirical testing requirements to ensure the validity of outcomes.
World Science Forum 2017 Jordan issues Science for Peace Declaration
On behalf of the coordinating organizations responsible for delivering the World Science Forum Jordan, the concluding Science for Peace Declaration issued at the Dead Sea represents a global call for action to science and society to build a future that promises greater equality, security and opportunity for all, and in which science plays an increasingly prominent role as an enabler of fair and sustainable development.
PETA science group promotes animal-free science at society of toxicology conference
The PETA International Science Consortium Ltd. is presenting two posters on animal-free methods for testing inhalation toxicity at the 56th annual Society of Toxicology (SOT) meeting March 12 to 16, 2017, in Baltimore, Maryland.
Citizen Science in the Digital Age: Rhetoric, Science and Public Engagement
James Wynn's timely investigation highlights scientific studies grounded in publicly gathered data and probes the rhetoric these studies employ.
Science/Science Careers' survey ranks top biotech, pharma, and biopharma employers
The Science and Science Careers' 2016 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.
Three natural science professors win TJ Park Science Fellowship
Professor Jung-Min Kee (Department of Chemistry, UNIST), Professor Kyudong Choi (Department of Mathematical Sciences, UNIST), and Professor Kwanpyo Kim (Department of Physics, UNIST) are the recipients of the Cheong-Am (TJ Park) Science Fellowship of the year 2016.
More Science News and Science Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Our Relationship With Water
We need water to live. But with rising seas and so many lacking clean water – water is in crisis and so are we. This hour, TED speakers explore ideas around restoring our relationship with water. Guests on the show include legal scholar Kelsey Leonard, artist LaToya Ruby Frazier, and community organizer Colette Pichon Battle.
Now Playing: Science for the People

#568 Poker Face Psychology
Anyone who's seen pop culture depictions of poker might think statistics and math is the only way to get ahead. But no, there's psychology too. Author Maria Konnikova took her Ph.D. in psychology to the poker table, and turned out to be good. So good, she went pro in poker, and learned all about her own biases on the way. We're talking about her new book "The Biggest Bluff: How I Learned to Pay Attention, Master Myself, and Win".
Now Playing: Radiolab

First things first: our very own Latif Nasser has an exciting new show on Netflix. He talks to Jad about the hidden forces of the world that connect us all. Then, with an eye on the upcoming election, we take a look back: at two pieces from More Perfect Season 3 about Constitutional amendments that determine who gets to vote. Former Radiolab producer Julia Longoria takes us to Washington, D.C. The capital is at the heart of our democracy, but it's not a state, and it wasn't until the 23rd Amendment that its people got the right to vote for president. But that still left DC without full representation in Congress; D.C. sends a "non-voting delegate" to the House. Julia profiles that delegate, Congresswoman Eleanor Holmes Norton, and her unique approach to fighting for power in a virtually powerless role. Second, Radiolab producer Sarah Qari looks at a current fight to lower the US voting age to 16 that harkens back to the fight for the 26th Amendment in the 1960s. Eighteen-year-olds at the time argued that if they were old enough to be drafted to fight in the War, they were old enough to have a voice in our democracy. But what about today, when even younger Americans are finding themselves at the center of national political debates? Does it mean we should lower the voting age even further? This episode was reported and produced by Julia Longoria and Sarah Qari. Check out Latif Nasser's new Netflix show Connected here. Support Radiolab today at